Danaher | DHR - Umsatzerlöse

Aktienkurs
178.80
Täglich Wechseln
-0.18 -0.10%
Monatlich
-2.77%
Jährlich
-10.30%
Q2 Prognose
173.46




Der Umsatz Veränderung Datum
Abbott USD 11.16B 300M 2026-03
Agilent USD 1.8B 63M 2025-12
Align Technology USD 1.04B 10M 2026-03
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Bio Techne USD 295.9M 9.34M 2025-12
Bio-Rad Laboratories USD 693.2M 40.2M 2025-12
Boston Scientific USD 5.2B 90M 2026-03
Bruker USD 977.2M 116.7M 2025-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 961M 57M 2025-12
Edwards Lifesciences USD 1.65B 80M 2026-03
ESCO Technologies USD 289.6M 63.07M 2025-12
Fortive USD 1.12B 90M 2025-12
Henry Schein USD 3.4B 60M 2025-12
Illumina USD 1.16B 80M 2025-12
Intuitive Surgical USD 2.77B 100M 2026-03
IQVIA Holdings USD 4.36B 260M 2025-12
Keysight Technologies USD 1.6B 181M 2025-12
Laboratory Of America USD 3.52B 40M 2025-12
Medtronic USD 9B 39M 2026-01
Mettler Toledo International USD 1.13B 100M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Quest Diagnostics USD 2.9B 90M 2026-03
Quidel USD 724M 24M 2025-12
Repligen USD 197.91M 8.91M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Roper Industries USD 2.1B 40M 2026-03
Stryker USD 7.2B 1.14B 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Waters USD 932M 132M 2025-12
Zimmer Biomet Holdings USD 2.09B 150M 2026-03